HEAL logo

Global X HealthTech ETF (HEAL)

$26.18

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on HEAL

AUM

$26186497

P/E ratio

35.1

Dividend yield

0.3193%

Expense ratio

0.5%

Beta

1.124255

Price on HEAL

Previous close

$25.80

Today's open

$25.59

Day's range

$25.59 - $26.30

52 week range

$23 - $33.59

Profile about HEAL

show more

Headquarters

US

Exchange

NASDAQ Global Market

Issue type

Exchange-Traded Fund

HEAL industries and sectors

Industries

Health

News on HEAL

Restart Life Advances AI-Driven E-Commerce Strategy to Scale Online Sales Growth for Holy Crap Foods

Vancouver, British Columbia--(Newsfile Corp. - June 18, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foods Inc., is preparing to begin harnessing predictive AI to further its e-commerce consumer and wholesale sales platform. The initiative is engineered to leverage readily available predictive consumer behavior models to optimize, monetize, and scale the brand's direct-to-consumer and business-to-business reach.

news source

Newsfile Corp • Jun 18, 2026

news preview

Medical Technology Stocks: Innovation Endures As Valuations Reset

Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.

news source

Seeking Alpha • May 2, 2026

news preview

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Survey data underscored how the war in the Middle East has already had a material impact on economic growth around the world. Drilling down deeper, the data showed weaker growth trends were recorded across all major industries globally.

news source

Seeking Alpha • Apr 12, 2026

news preview

Investing In Health Stocks - How Policy Clarity Is Opening Doors

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.

news source

Seeking Alpha • Nov 11, 2025

news preview

Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs

The U.S. Food and Drug Administration's recent enforcement action against drug promotion is sending ETFs with exposure to weight-loss treatment manufacturers into question.

news source

Benzinga • Sep 18, 2025

news preview

Global X Announces Five ETF Reverse Stock Splits

NEW YORK, Aug. 18, 2025 /PRNewswire/ -- Global X Management Company, LLC ("Global X"), the New York-based provider of exchange traded funds (ETFs), today announced reverse splits of the following five funds (each a "Fund" or collectively, "Funds")

news source

PRNewsWire • Aug 18, 2025

news preview

¹ Disclosures

Get started with M1

Invest in Global X HealthTech ETF

Open an M1 investment account to buy and sell Global X HealthTech ETF commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in HEAL on M1